Bilateral Optic Neuritis as an Atypical Presentation of Primary Sjögren's Syndrome (pSS)
Downloads
Introduction: Primary Sjögren's syndrome (pSS) is a chronic progressive autoimmune disease that primarily affects exocrine glands with varying symptoms. Here we discuss atypical optic neuritis as an initial presentation of pSS without any sicca symptoms. Case presentation: A 22-year-old woman came to the outpatient clinic with the chief complaint of rapid deteriorating visual acuity that had started one week before”no complaint of the eye or other mucosal dryness. At the initial visit, best corrected visual acuity (BCVA) was hand movement on the right eye and 6/7.5 on the left eye with decreasing color perception. Fundus examination showed bilateral optic nerve head edema. Schirmer test and tear-film break up time were within normal limits. After the initial one gram intravenous methylprednisolone treatment, no significant changes were observed for three consecutive days. Serological investigations revealed raised levels of SS-A native. Improvement happened after being given azathioprine. Conclusion: Optic neuritis may be the initial presentation of Sjögren's syndrome without sicca symptoms. The presence of a specific antibody, including anti-SSA, is supportive for the diagnosis of such a case.
Hoorbakht H, Bagherkashi F. Optic neuritis: Its differential diagnosis and management. Open Ophthalmol J 2012;6:65–72. https://doi.org/10.2174/1874364101206010065.
Bowling B. Kanski's Clinical Ophthalmology. 8th ed. London: W B Saunders; 2015.
Tang W-Q, Wei S-H. Primary Sjögren's syndrome related optic neuritis. Int J Ophthalmol 2013;6:888–891. https://doi.org/10.3980/j.issn.2222-3959.2013.06.26.
Toosy AT, Mason DF, Miller DH. Optic neuritis. Lancet Neurol 2014;13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X.
Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al. 2016 American college of rheumatology/European league against rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol (Hoboken, NJ) 2017;69:35–45. https://doi.org/10.1002/art.39859.
Sun J-Y, Liu Z, Zhao P, Liu T. Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review. Medicine (Baltimore) 2016;95:e5194. https://doi.org/10.1097/MD.0000000000005194.
Colaci M, Cassone G, Manfredi A, Sebastiani M, Giuggioli D, Ferri C. Neurologic complications associated with Sjögren's disease: Case reports and modern pathogenic dilemma. Case Rep Neurol Med 2014;2014:590292. https://doi.org/10.1155/2014/590292.
Tobón GJ, Pers J-O, Devauchelle-Pensec V, Youinou P. Neurological disorders in primary Sjögren's syndrome. Autoimmune Dis 2012;2012:645967. https://doi.org/10.1155/2012/645967.
Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, et al. Central nervous system involvement in Sjögren's syndrome: Unusual, but not unremarkable--clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford) 2010;49:1540–1549. https://doi.org/10.1093/rheumatology/keq111.
Bak E, Yang HK, Hwang J-M. Optic neuropathy associated with primary Sjögren's syndrome: A case series. Optom Vis Sci Off Publ Am Acad Optom 2017;94:519–526. https://doi.org/10.1097/OPX.0000000000001054.
Min JH, Kim HJ, Kim BJ, Lee KW, Sunwoo IN, Kim SM, et al. Brain abnormalities in Sjogren syndrome with recurrent CNS manifestations: Association with neuromyelitis optica. Mult Scler 2009;15:1069–1076. https://doi.org/10.1177/1352458509106228.
Toker E, Yavuz S, Direskeneli H. Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndrome. Br J Ophthalmol 2004;88:384–387. https://doi.org/10.1136/bjo.2003.028340.
Hernández-Molina G, Leal-Alegre G, Michel-Peregrina M. The meaning of anti-Ro and anti-La antibodies in primary Sjögren's syndrome. Autoimmun Rev 2011;10:123–125. https://doi.org/10.1016/j.autrev.2010.09.001.
Tan P, Yu WY, Umapathi T, Lim S-A. Severe optic neuritis in a patient with combined neuromyelitis optica spectrum disease and primary Sjögren's syndrome: A case report. J Med Case Rep 2012;6:401. https://doi.org/10.1186/1752-1947-6-401.
Nitescu D, Nicolau A, Caraiola S, Predeteanu D, Ionescu R, Tanasescu C. Neuromyelitis optica--complication or comorbidity in primary Sjögren's syndrome? Rom J Intern Med 2011;49:295–300.
Wingerchuk DM, Weinshenker BG. The emerging relationship between neuromyelitis optica and systemic rheumatologic autoimmune disease. Mult Scler 2012;18:5–10. https://doi.org/10.1177/1352458511431077.
Kahlenberg JM. Neuromyelitis optica spectrum disorder as an initial presentation of primary Sjögren's syndrome. Semin Arthritis Rheum 2011;40:343–348. https://doi.org/10.1016/j.semarthrit.2010.05.005.
Adler S, Villiger PM. Inhibitors of T cell Activation in the Treatment of Sjögren's Syndrome. Curr Treat Options Rheumatol 2015;1:269–276. https://doi.org/10.1007/s40674-015-0024-5.
Saxena R, Phuljhele S, Menon V, Gadaginamath S, Sinha A, Sharma P. Clinical profile and short-term outcomes of optic neuritis patients in India. Indian J Ophthalmol 2014;62:265–267. https://doi.org/10.4103/0301-4738.121131.
Beck RW, Cleary PA, Anderson MMJ, Keltner JL, Shults WT, Kaufman DI, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group. N Engl J Med 1992;326:581–588. https://doi.org/10.1056/NEJM199202273260901.
Copyright (c) 2022 Denisa Rosati, Lukisiari Agustini
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Vision Science and Eye Health Journal by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The journal allows the author to hold the copyright of the article without restrictions.
The journal allows the author(s) to retain publishing rights without restrictions.
The legal formal aspect of journal publication accessibility refers to Creative Commons Attribution-Share-Alike (CC BY-SA).
The Creative Commons Attribution-Share-Alike (CC BY-SA) license allows re-distribution and re-use of a licensed work on the conditions that the creator is appropriately credited and that any derivative work is made available under "the same, similar or a compatible license”. Other than the conditions mentioned above, the editorial board is not responsible for copyright violations.
